articleTop 1% cited

Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection

The American Journal of Gastroenterology · 2012 · Vol. 107(7) · pp. 1079–1087

Lawrence J. Brandt✉(Montefiore Medical Center)Olga C. Aroniadis(Montefiore Medical Center)Mark Mellow(INTEGRIS Baptist Medical Center)Amy Kanatzar(INTEGRIS Baptist Medical Center)Colleen Kelly(Brown University)Tina Park(Brown University)Neil Stollman(University of California, San Francisco)Faith Rohlke(University of Illinois Chicago)Christina M. Surawicz(University of Washington)

View via DOI Publisher page

Abstract

FMT is a rational, durable, safe, and acceptable treatment option for patients with recurrent CDI.

Clostridium difficile and Clostridium perfringens research Microscopic Colitis Helicobacter pylori-related gastroenterology studiesClostridium difficileMedicineFecal bacteriotherapyFecesClostridium InfectionsMicrobiologyColonoscopyGastroenterologyInternal medicineAntibiotics

MeSH terms

AgedAnti-Bacterial AgentsColonoscopyEnterocolitis, PseudomembranousFecesFemaleFollow-Up StudiesHumansLongitudinal StudiesMaleSurveys and QuestionnairesRecurrenceUnited StatesVancomycinClostridioides difficile

Citations

664

FWCI

37.07

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory <i>Clostridium difficile</i> infection